|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| C07K 16/30 | |||
| C07K 16/46 | |||
| C07K 16/22 |
| (11) | Number of the document | 2552960 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11711071.8 |
| Date of filing the European patent application | 2011-03-24 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/054504 |
| Date | 2011-03-24 |
| (87) | Number | WO 2011/117329 |
| Date | 2011-09-29 |
| (30) | Number | Date | Country code |
| 10003269 | 2010-03-26 | EP |
| (72) |
BAEHNER, Monika, DE
IMHOF-JUNG, Sabine, DE
KAVLIE, Anita, NO
KETTENBERGER, Hubert, DE
KLEIN, Christian, CH
REGULA, Joerg, Thomas, DE
SCHAEFER, Wolfgang, DE
SCHANZER, Juergen, Michael, DE
SCHEUER, Werner, DE
STUBENRAUCH, Kay-Gunnar, DE
THOMAS, Markus, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES |
| BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES |